Jacobson's Progressive Muscle Relaxation Technique With Aerobic Exercise on Cardiopulmonary Parameters and Quality of Life in Stage 1 Hypertensive Individuals

NCT ID: NCT06997445

Last Updated: 2025-09-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-08-02

Study Completion Date

2025-06-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study is a randomized controlled trial. The purpose of study is to compare the additive effects of Jacobson's progressive muscle relaxation technique with aerobic exercise versus aerobic exercise on cardiopulmonary parameters including systolic and diastolic blood pressure, heart rate, respiratory rate, rate pressure product and quality of life in stage 1 hypertensive individuals.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study will consist of referred stage 1 hypertensive patients by medical specialist/cardiologist.

Participants will be screened through PAR-Q and IPAQ Questionnaire. Cardiac monitor will be used for assessing the cardiopulmonary parameters. SF-36 Questionnaire will be used for assessing the quality of life. Informed written consent will be taken after which participants will be recruited into two groups.

Control group will be provided aerobic exercise while interventional group will be provided Jacobson's progressive muscle relaxation technique with aerobic exercise.

Outcome measures assessment will be done at pre-session, at 2 weeks and after 4 weeks post-intervention

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypertension

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Interventional group

Patients in interventional group will receive Jacobson's progressive muscle relaxation technique for 15 minutes and aerobic exercise for 30 minutes.

For Jacobson's progressive muscle relaxation technique first patient is asked to clench each fist separately, fee the tension, release the fist and relax. Then bend each arm separately, feel the tension and then release the arm. Then straighten the arm separately, feel the tension and then relax. Then wrinkle the forehead, feel the tension and then release the eyebrows relax. Then close the eyes and screw the muscles around the eyes and then release. Then tense the jaw by biting the teeth together and relax. Then press the tongue hard and flat against roof of mouth, feel the tension and then relax. Then push the head back and then bring head back to position. Then bring the head down and then relax. Then shrug the shoulders and relax. Then take a deep breath, hold and then relax. Then tense the stomach muscle and then release. Then arch

Group Type ACTIVE_COMPARATOR

Interventional group: Jacobson's progressive muscle relaxation technique with aerobic exercise

Intervention Type OTHER

Jacobaon's progressive muscle relaxation technique for 15 minutes Total duration: 45 minutes

Control group

The control group will receive only aerobic exercise for 45 minutes. Aerobic exercise will include warm uo exercises for 5 minutes, brisk walking on treadmill for 25 minutes which include warm up period for 10 minutes then 14 minutes brisk walk and cool down period included 1 minute walk, stepper for 5 minutes, static cycling for 5 minutes and cool down for 5 minutes.

Total 4 weeks protocol. Before and after 4 weeks, pre and post intervention values will be taken.

A total of 20 sessions five days per week for 4 weeks will be provided supervised by physiotherapist

Group Type OTHER

Aerobic Exercise

Intervention Type OTHER

Participants in this group will only be provided aerobic exercise for 4 weeks supervised by physiotherapist.

Aerobic Exercise include the following:

* Warm up exercises for 5 minutes.
* Brisk walking on treadmill for 25 minutes which include warm up period for 10 minutes then 14 minutes brisk walk and cool down period included 1 minute walk.
* Stepper for 5 minutes.
* Static cycling for 5 minutes.
* Cool down for 5 minutes.

Week 03 and Week 04:

Frequency: 5 days per week Intensity: 60-80% Target heart rate Time: 45 minutes

Week 01 and Week 02:

Frequency: 5 days per week Intensity: 50-60 % Target heart rate Time: 45 minutes

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Interventional group: Jacobson's progressive muscle relaxation technique with aerobic exercise

Jacobaon's progressive muscle relaxation technique for 15 minutes Total duration: 45 minutes

Intervention Type OTHER

Aerobic Exercise

Participants in this group will only be provided aerobic exercise for 4 weeks supervised by physiotherapist.

Aerobic Exercise include the following:

* Warm up exercises for 5 minutes.
* Brisk walking on treadmill for 25 minutes which include warm up period for 10 minutes then 14 minutes brisk walk and cool down period included 1 minute walk.
* Stepper for 5 minutes.
* Static cycling for 5 minutes.
* Cool down for 5 minutes.

Week 03 and Week 04:

Frequency: 5 days per week Intensity: 60-80% Target heart rate Time: 45 minutes

Week 01 and Week 02:

Frequency: 5 days per week Intensity: 50-60 % Target heart rate Time: 45 minutes

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adults: aged (18-45 years)
* Gender: both male and female
* Patients diagnosed with stage 1 hypertension (130-139 / 80-89 mmHg according to AHA/ACC 2017 guidelines
* Mild to moderate physical activity level on IPAQ Questionnaire
* Individuals who are able to understand and follow the instructions for exercise

Exclusion Criteria

* Unstable angina, MI, heart failure, advanced CAD patients
* Severe neurological, musculoskeletal, or gynaecological conditions which limit participation in study
* Recent history of fracture
* Morbidly obese (BMI \> 40.0 kg / m2)
Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Foundation University Islamabad

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Foundation University College of Physical Therapy, Islamabad, 44000

Islamabad, , Pakistan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Pakistan

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

FUI/CTR/2024/71

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.